SYCP1 and neoplasm: In their study, samples from three groups (PA, residual PA, and CXPA) were analyzed to identify protein signatures and their results suggested that seven proteins (APOA1, AP1M1, SYCP1, DCD, HBB, HP, and SLC4A1) could be potential signatures for tumor progression or suppression.